FOIA to FDA Seeking Records Related to BARDA Director’s Potentially Improper Dismissal
FOIA to FDA seeking communications related to the dismissal of BARDA Director Rick Bright, who reportedly resisted efforts to push untested coronavirus treatments. HHS-FDA-20-1105